
Uncategorized
FDA approves Tecentriq in combination with Cotellic and Zelboraf for patients with advanced skin cancer
Dr. Dan, Gryt Health Chief Medical Officer, breaks down what you need to know about the newly approved, as of January 2021, immunotherapy treatment for melanoma, tecentriq.